- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Senzime AB (SEZI)
Senzime AB stock price live, this page displays ST SEZI stock exchange data. View the SEZI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Senzime AB real time stock price chart below.
What Is the Senzime AB Stock Price Today?
The Senzime AB stock price today is 7.0200.
What Is the Stock Symbol for Senzime AB?
The stock symbol for Senzime AB is ""SEZI.""
What Stock Exchange Does Senzime AB Trade On?
Senzime AB is listed and trades on the Stockholm stock exchange.
Is Senzime AB a Good Stock to Buy?
Determining whether Senzime AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SEZI quote. (ISIN: SE0002478776)
What Is the Senzime AB Stock Price Today?
The Senzime AB stock price today is 7.0200.
What Is the Stock Symbol for Senzime AB?
The stock symbol for Senzime AB is ""SEZI.""
What Stock Exchange Does Senzime AB Trade On?
Senzime AB is listed and trades on the Stockholm stock exchange.
Is Senzime AB a Good Stock to Buy?
Determining whether Senzime AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SEZI quote. (ISIN: SE0002478776)
Stockholm
Currency in SEK
7.0200
-0.2500(-3.44%)
Closed·
Fair Value
An estimate of a Senzime's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.9100
7.3400
52 wk Range
3.6000
9.6000
SEZI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SEZI is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Senzime's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.91007.3400
52 wk Range
3.60009.6000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SEZI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Senzime's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Senzime AB Company Profile
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. It provides TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue’s opposition to carrying an alternating electrical current. The company has a strategic connectivity and licensing agreement with Masimo to develop, manufacture, market, and distribute products that can connect to the Masimo Root patient monitoring system and related digital hub for data transmission to hospital electronic patient journals; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system. Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.
Senzime AB Earnings Call Summary for Q2/2025
- Senzime reports 90% sales growth in Q2 2025, with U.S. market now representing 72% of total business
- Gross margin reaches 61.7%, EBITDA improves by 23%, and installed base of TETRAGRAPH units exceeds 4,100
- Company maintains annual guidance, plans price adjustments to offset tariffs, and aims to expand into pediatric monitoring
- CEO emphasizes 'hyper-growth phase' and commitment to global accessibility of advanced technology
- Analysts forecast 90% sales growth for FY2025, though profitability not expected this year
Last Updated: 18/07/2025, 14:00
Read Full TranscriptCompare SEZI to Peers and Sector
Metrics to compare | SEZI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSEZIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.7x | −10.6x | −0.5x | |
PEG Ratio | −0.54 | −0.10 | 0.00 | |
Price/Book | 3.0x | 2.9x | 2.6x | |
Price / LTM Sales | 13.7x | 817.8x | 3.3x | |
Upside (Analyst Target) | 82.3% | 0.0% | 45.4% | |
Fair Value Upside | Unlock | 5.0% | 7.7% | Unlock |
Earnings
Latest Release
Jul 18, 2025
EPS / Forecast
-0.22 / -0.17
Revenue / Forecast
25.70M / 24.90M
FAQ
What Stock Exchange Does Senzime Trade On?
Senzime is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Senzime?
The stock symbol for Senzime is "SEZI."
What Is the Senzime Market Cap?
As of today, Senzime market cap is 1.10B.
What Is Senzime's Earnings Per Share (TTM)?
The Senzime EPS (TTM) is -0.97.
When Is the Next Senzime Earnings Date?
Senzime will release its next earnings report on 06 Nov 2025.
From a Technical Analysis Perspective, Is SEZI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Senzime Stock Split?
Senzime has split 7 times.
How Many Employees Does Senzime Have?
Senzime has 54 employees.
What is the current trading status of Senzime (SEZI)?
As of 03 Aug 2025, Senzime (SEZI) is trading at a price of 7.02, with a previous close of 7.27. The stock has fluctuated within a day range of 6.91 to 7.34, while its 52-week range spans from 3.60 to 9.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.